시간 외 거래: 17.507 0.087 +0.50%

TG테라퓨틱스사 (TGTX)

TG Therapeutics Inc 주식(TGTX)의 최신 뉴스

TG테라퓨틱스사 (TGTX)

TG Therapeutics Inc 주식(TGTX)의 최신 뉴스

TG Therapeutics (TGTX) Stock Moves -0.6%: What You Should Know - Yahoo Singapore News

TG Therapeutics Announces Presentation of Data from the ULTIMATE I & II Phase 3 Trials of BRIUMVI™ (ublituximab ... - br.ADVFN.com

(TGTX) Trading Report - Stock Traders Daily

U.S. FDA approves TG Therapeutics' multiple sclerosis drug; shares surge - Yahoo Movies Canada

AMC Entertainment, TG Therapeutics and Interesting findings in the market, within your browser - FOREX.com

Wall Street Breakfast: The Week Ahead

TG Therapeutics (TGTX) Withdraws FDA Submission, Stock Down - Yahoo Canada Shine On

TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

TG Therapeutics, Inc. (NASDAQ:TGTX) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World

TG Therapeutics (TGTX) Stock Moves -0.6%: What You Should Know - Yahoo Singapore News

FY2025 Earnings Estimate for TG Therapeutics, Inc. (NASDAQ:TGTX) Issued By HC Wainwright - MarketBeat

Q2 2024 Earnings Forecast for TG Therapeutics, Inc. Issued By B. Riley (NASDAQ:TGTX) - Defense World

TG Therapeutics, Inc. to Post FY2025 Earnings of $0.11 Per Share, HC Wainwright Forecasts (NASDAQ:TGTX) - Defense World

FY2025 Earnings Estimate for TG Therapeutics, Inc. (NASDAQ:TGTX) Issued By HC Wainwright - MarketBeat

TG Therapeutics, Inc. (NASDAQ:TGTX) to Post FY2025 Earnings of $0.72 Per Share, B. Riley Forecasts - Defense World

TG Therapeutics, Inc. (NASDAQ:TGTX) to Post FY2025 Earnings of $0.72 Per Share, B. Riley Forecasts - MarketBeat

Earnings call: TG Therapeutics sees strong Q1 growth with Briumvi - Investing.com

TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2024 Earnings Call Transcript - Insider Monkey

News Flash: Analysts Just Made A Meaningful Upgrade To Their TG Therapeutics, Inc. (NASDAQ:TGTX) Forecasts - Simply Wall St

Why TG Therapeutics Stock Was Rocketing Higher This Week - MSN

Why TG Therapeutics Stock Was Rocketing Higher This Week

TG Therapeutics, Inc. (NASDAQ:TGTX) to Post FY2025 Earnings of $0.72 Per Share, B. Riley Forecasts - MarketBeat

TG Therapeutics, Inc. (NASDAQ:TGTX) Forecasted to Post Q2 2024 Earnings of ($0.05) Per Share - Defense World

B. Riley Research Analysts Increase Earnings Estimates for TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat

TG Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

TG Therapeutics: Q1 Earnings Snapshot - Milford Mirror

TG Therapeutics (NASDAQ:TGTX) Shares Gap Up to $13.66 - MarketBeat

TG Therapeutics, Inc. (NASDAQ:TGTX) Expected to Post FY2026 Earnings of $1.60 Per Share - MarketBeat

TG Therapeutics (TGTX) Reports Q1 Loss, Tops Revenue Estimates

TG Therapeutics Target of Unusually Large Options Trading (NASDAQ:TGTX) - MarketBeat

TG Therapeutics to Host Conference Call on First Quarter 2024 Financial Results and Business Update

After Plunging -9.82% in 4 Weeks, Here's Why the Trend Might Reverse for TG Therapeutics (TGTX)

17500 Shares in TG Therapeutics, Inc. (NASDAQ:TGTX) Bought by Strs Ohio - Defense World

After Plunging -9.82% in 4 Weeks, Here's Why the Trend Might Reverse for TG Therapeutics (TGTX) - Yahoo Canada Finance

TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting

TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple Sclerosis

TG Therapeutics wins VA contract for MS drug - Investing.com Nigeria

TG Therapeutics: The Cloud Over Briumvi (NASDAQ:TGTX) - Seeking Alpha

TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting

TG Therapeutics highlights BRIUMVI data at AAN meeting - Investing.com

TG Therapeutics Breaks Below 200-Day Moving Average - Notable for TGTX - Nasdaq

Should You Invest in the SPDR S&P Biotech ETF (XBI)?

TG Therapeutics (NASDAQ:TGTX) Has A Somewhat Strained Balance Sheet - Simply Wall St

Is TG Therapeutics, Inc.'s (NASDAQ:TGTX) Recent Price Movement Underpinned By Its Weak Fundamentals? - Yahoo Finance

Director Laurence Charney Sells 22000 Shares of TG Therapeutics Inc (TGTX) - GuruFocus.com

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting

Rare Stock Picks In February 2024 - From 32 Discerning Analysts

TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

Earnings call: TG Therapeutics reports robust BRIUMVI sales in 2023 - Investing.com

Company News for Feb 29, 2024

TGTX과 유사한 종목